Skip to content

Evaluation of the rehabilitation efficacy of elderly patients with sarcopenia

Evaluation of the rehabilitation efficacy of elderly patients with sarcopenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043866
Enrollment
Unknown
Registered
2021-03-04
Start date
2021-03-02
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

treatment group:resistance training
control group:Nutritional support, aerobic training, neuromuscular electrical stimulation

Sponsors

Shanghai Fourth Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 95 Years

Inclusion criteria

Inclusion criteria: Aged >= 65 years; basic communication skills; muscle manual testing >= grade 3; SARC-F scale score >= 4; voluntary participation in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Acute changes in body composition, e.g. severe oedema, dehydration, etc.; unexplained fever or infection; patients who are unable to cooperate or have contraindications to body composition measurements, SPPB measurements, grip strength measurements, ultrasound diaphragm examinations, CT examinations; patients with acute heart failure, renal failure, respiratory failure and contraindications to rehabilitation training; patients with neurological, muscular or joint disorders that may affect lower limb exercise training or NMES; patients who have participated in rehabilitation training in the past 1 month.

Design outcomes

Primary

MeasureTime frame
Skeletal muscle mass index at the lumbar 3 vertebral level;Short physical performance battery;Grip strength;Body weight;Height;Waist circumference;Hip circumference;Neck circumference;Thigh circumference;Mid-thigh circumference;Skinfold thickness;Fat-free mass;Skeletal muscle mass;Fat area at the lumbar 3 vertebral level;Activity of daily living ability assessment;Waist-to-hip ratio;BMI;Serum albumin;Blood glucose;glycosylated hemoglobin;Blood lipid;25 hydroxyvitamin D;Body fat rate;

Secondary

MeasureTime frame
Calf circumference;Hamilton Depression Scale;Hamilton Anxiety Scale;St. George’S Respiratory Questionnaire;Borg scale;Modified Medical Research Council Dyspnea Scale;Peak expiratory flow;6 minutes walking distance;Thickness of diaphragm;Diaphragm mobility;Liver and renal function;

Countries

China

Contacts

Public ContactYin Zhang

Shanghai Fourth Rehabilitation Hospital

fuga1080@hotmail.com+86 13916463260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026